Cerapedics Growth, Revenue, Number of Employees and Funding

Overview

Location:
Denver, CO USA
Total Funding:$112.3M
Industry:Biotech
Founded:2006
Lead Investor(s):KCK Group
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Cerapedics's estimated revenue is currently $8.4M per year.
  • Cerapedics received $22.0M in venture funding in July 2018.
  • Cerapedics's estimated revenue per employee is $144310
  • Cerapedics's total funding is $112.3M.

Employee Data

  • Cerapedics has 58 Employees.
  • Cerapedics grew their employee count by 38% last year.
  • Cerapedics currently has 1 job openings.

Executive Contacts

NameTitle
Jeffrey MarxPresident/COO
Katie DavisDirector of Research and Development
Rick PreusseDirector of Education and Training
Nitin ChawlaDirector of Marketing, US
Mark HegermanArea Director
Andrew BarnesVice President, US Sales
Jerome ConnorVP Research/Development
John LimpicArea Sales Director SouthWest
Tommy VollmarVice President of Marketing, Medical Education, & Healthcare Economics
Roger WhiteVP Clinical & Regulatory Affairs

What Is Cerapedics?

Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTOR Peptide Enhanced Bone Graft (P-15/ABM) is only the 2nd FDA PMA Approve bone graft on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year. i-FACTOR is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.

keywords:Biotechnology,Healthcare,Pharmaceuticals

58

Number of Employees

$8.4M

Revenue (est)

1

Current Jobs

38%

Employee Growth %

$112.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
MBio Diagnostic...
$5.1M3535%
Mile High Labs
$26.2M181596%$100M
GlobeImmune
$5.1M350%
Isolate Extract...
$6.4M4433%
Front Range Bio...
$7.3M5067%
Inscripta
$15.8M10954%$134.2M
ArcherDX
$33.3M23064%$95M
Clovis Oncology
$95.4M54011%$763.3M
miRagen Therape...
$3.9M8619%public
Biodesix
$19.1M15619%$182M

Cerapedics News

07/08/2019 - Cerapedics Announces Expansion of Colorado Headquarters

WESTMINSTER, Colo., July 8, 2019 /PRNewswire/ -- Cerapedics, a private ortho-biologics company, today announced the expansion of the ...

03/06/2019 - Cerapedics Announces ISASS Bone Grafting Policy Statement ...

WESTMINSTER, Colo., March 6, 2019 /PRNewswire/ -- Cerapedics, a privately-held orthobiologics company, today announced that the ...

07/09/2019 - Cerapedics Expands Headquarters in Denver, Colorado Area

Cerapedics, a private ortho-biologics company, plans an expansion of the company's headquarters located in metro Denver, Colorado.

Cerapedics Funding

DateAmountRoundLead InvestorsReference
2009-04-03$15.0MBArticle
2012-12-13$19.0MCMedImmune Ventures, CVF LLCArticle
2014-04-15$9.0MUndisclosedGE CapitalArticle
2015-02-25$4.0MUndisclosedArticle
2015-04-08$8.0MUndisclosedGE CapitalArticle
2016-09-30$11.0MDArticle
2017-04-20$20.0MUndisclosedOxford FinanceArticle
2018-07-16$22.0MUndisclosedKCK GroupArticle

Cerapedics Executive Hires

DateNameTitleReference
2013-05-17Glen A. KashubaCEOArticle
2017-10-26Antony KoblishChairArticle